Biotech Values

[urche]

GTCB CC


I thought the CC went smoothly and it answered my questions as well as I could expect. I liked your question, BTW. Maybe I am naive, but for a small company that has been marginally surviving I have to give it credit for not flubbing its PRs or CCs. It seems to be able to present a consistent and reputable public personae.

I am a bit surprised at the reaction with stock price up about 7%. I was expecting a dip and buying opportunity by reading into the PR that another stock offering is very likely in first half of 2005 in order to launch ATryn.

I guess this company goes back on the back burner for a while. I expect the next newsworthy item will be announcing ATryn partner (without financial details) in December.

What did you think of the CC?


Urche